Ping-Ying Pan

7PUBLICATIONS
49CO-AUTHORS
Molecular targetsHaematological tumoursInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 27, 2026
Potentiation of a Porous Silicon Therapeutic Vaccine in Colorectal Cancer via Oxaliplatin-Mediated Regulation of Myeloid-Driven Immunosuppression.

|Feb 13, 2025
Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4.

Yitian Xu, Kyeongah Kang, Brian A Coakley

|Dec 15, 2023
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.

Sunny Mai, Alan Hodges, Hui-Ming Chen

|Mar 16, 2023
Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell Profiles.

Yitian Xu, Licheng Zhang, Jose Thaiparambil

|Dec 15, 2021
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.

Andrew W Chung, Kartik Anand, Ann C Anselme

|Nov 13, 2021
The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells.

Louis Hinkle, Yongbin Liu, Chaoyang Meng

Pageof 2

Frequent Collaborators

4 joint publications

Shu-Hsia Chen

3 joint publications

Licheng Zhang

3 joint publications

Yitian Xu

2 joint publications

Yongbin Liu